Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft

Chemokines such as monocyte chemoattractant protein (MCP)-1 are key agonists that attract macrophages to tumors. In melanoma, it has been previously shown that variable levels of MCP-1/CCL2 appear to correlate with infiltrating macrophages and tumor fate, with low to intermediate levels of the chemo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2007
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0022202X_v127_n8_p2031_Gazzaniga
http://hdl.handle.net/20.500.12110/paper_0022202X_v127_n8_p2031_Gazzaniga
Aporte de:
id paper:paper_0022202X_v127_n8_p2031_Gazzaniga
record_format dspace
spelling paper:paper_0022202X_v127_n8_p2031_Gazzaniga2023-06-08T14:47:21Z Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft 2 methyl 2 [(1 (phenylmethyl) 1h indazol 3yl)methoxy]propanoic acid clodronic acid monocyte chemotactic protein 1 propionic acid derivative unclassified drug animal cell animal experiment animal model animal tissue article cancer inhibition controlled study expression vector genetic transfection human human cell melanoma mouse nonhuman priority journal tumor associated leukocyte tumor growth tumor necrosis tumor vascularization xenograft Animals Antigens, CD31 Cell Line, Tumor Chemokine CCL2 Clodronic Acid Humans Indazoles Liposomes Macrophages Male Melanoma, Experimental Mice Neoplasm Transplantation Neovascularization, Pathologic Propionic Acids Transplantation, Heterologous Chemokines such as monocyte chemoattractant protein (MCP)-1 are key agonists that attract macrophages to tumors. In melanoma, it has been previously shown that variable levels of MCP-1/CCL2 appear to correlate with infiltrating macrophages and tumor fate, with low to intermediate levels of the chemokine contributing to melanoma development. To work under such conditions, a poorly tumorigenic human melanoma cell line was transfected with an expression vector encoding MCP-1. We found that M2 macrophages are associated to MCP-1+ tumors, triggering a profuse vascular network. To target the protumoral macrophages recruitment and reverting tumor growth promotion, clodronate-laden liposomes (Clod-Lip) or bindarit were administered to melanoma-bearing mice. Macrophage depletion after Clod-Lip treatment induced development of smaller tumors than in untreated mice. Immunohistochemical analysis with an anti-CD31 antibody revealed scarce vascular structures mainly characterized by narrow vascular lights. Pharmacological inhibition of MCP-1 with bindarit also reduced tumor growth and macrophage recruitment, rendering necrotic tumor masses. We suggest that bindarit or Clod-Lip abrogates protumoral-associated macrophages in human melanoma xenografts and could be considered as complementary approaches to antiangiogenic therapy. © 2007 The Society for Investigative Dermatology. 2007 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0022202X_v127_n8_p2031_Gazzaniga http://hdl.handle.net/20.500.12110/paper_0022202X_v127_n8_p2031_Gazzaniga
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic 2 methyl 2 [(1 (phenylmethyl) 1h indazol 3yl)methoxy]propanoic acid
clodronic acid
monocyte chemotactic protein 1
propionic acid derivative
unclassified drug
animal cell
animal experiment
animal model
animal tissue
article
cancer inhibition
controlled study
expression vector
genetic transfection
human
human cell
melanoma
mouse
nonhuman
priority journal
tumor associated leukocyte
tumor growth
tumor necrosis
tumor vascularization
xenograft
Animals
Antigens, CD31
Cell Line, Tumor
Chemokine CCL2
Clodronic Acid
Humans
Indazoles
Liposomes
Macrophages
Male
Melanoma, Experimental
Mice
Neoplasm Transplantation
Neovascularization, Pathologic
Propionic Acids
Transplantation, Heterologous
spellingShingle 2 methyl 2 [(1 (phenylmethyl) 1h indazol 3yl)methoxy]propanoic acid
clodronic acid
monocyte chemotactic protein 1
propionic acid derivative
unclassified drug
animal cell
animal experiment
animal model
animal tissue
article
cancer inhibition
controlled study
expression vector
genetic transfection
human
human cell
melanoma
mouse
nonhuman
priority journal
tumor associated leukocyte
tumor growth
tumor necrosis
tumor vascularization
xenograft
Animals
Antigens, CD31
Cell Line, Tumor
Chemokine CCL2
Clodronic Acid
Humans
Indazoles
Liposomes
Macrophages
Male
Melanoma, Experimental
Mice
Neoplasm Transplantation
Neovascularization, Pathologic
Propionic Acids
Transplantation, Heterologous
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
topic_facet 2 methyl 2 [(1 (phenylmethyl) 1h indazol 3yl)methoxy]propanoic acid
clodronic acid
monocyte chemotactic protein 1
propionic acid derivative
unclassified drug
animal cell
animal experiment
animal model
animal tissue
article
cancer inhibition
controlled study
expression vector
genetic transfection
human
human cell
melanoma
mouse
nonhuman
priority journal
tumor associated leukocyte
tumor growth
tumor necrosis
tumor vascularization
xenograft
Animals
Antigens, CD31
Cell Line, Tumor
Chemokine CCL2
Clodronic Acid
Humans
Indazoles
Liposomes
Macrophages
Male
Melanoma, Experimental
Mice
Neoplasm Transplantation
Neovascularization, Pathologic
Propionic Acids
Transplantation, Heterologous
description Chemokines such as monocyte chemoattractant protein (MCP)-1 are key agonists that attract macrophages to tumors. In melanoma, it has been previously shown that variable levels of MCP-1/CCL2 appear to correlate with infiltrating macrophages and tumor fate, with low to intermediate levels of the chemokine contributing to melanoma development. To work under such conditions, a poorly tumorigenic human melanoma cell line was transfected with an expression vector encoding MCP-1. We found that M2 macrophages are associated to MCP-1+ tumors, triggering a profuse vascular network. To target the protumoral macrophages recruitment and reverting tumor growth promotion, clodronate-laden liposomes (Clod-Lip) or bindarit were administered to melanoma-bearing mice. Macrophage depletion after Clod-Lip treatment induced development of smaller tumors than in untreated mice. Immunohistochemical analysis with an anti-CD31 antibody revealed scarce vascular structures mainly characterized by narrow vascular lights. Pharmacological inhibition of MCP-1 with bindarit also reduced tumor growth and macrophage recruitment, rendering necrotic tumor masses. We suggest that bindarit or Clod-Lip abrogates protumoral-associated macrophages in human melanoma xenografts and could be considered as complementary approaches to antiangiogenic therapy. © 2007 The Society for Investigative Dermatology.
title Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
title_short Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
title_full Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
title_fullStr Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
title_full_unstemmed Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
title_sort targeting tumor-associated macrophages and inhibition of mcp-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
publishDate 2007
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0022202X_v127_n8_p2031_Gazzaniga
http://hdl.handle.net/20.500.12110/paper_0022202X_v127_n8_p2031_Gazzaniga
_version_ 1768543406091403264